Hospice News August 16, 2024
The outlook for the hospice M&A market is equal parts promising and potentially turbulent, with regulatory and reimbursement pressures among the challenges on investors’ radar.
Hospice merger and acquisition activity has seen a slump compared to previous record-breaking years.
Interest in the space isn’t anticipated to abate anytime soon, but hospice transactions are facing greater obstacles related to regulatory oversight and profitability, according to Mark Kulik, senior managing director at The Braff Group. Kulik is responsible for the M&A firm’s hospice, home health, home care, pediatric and private duty markets across the Eastern United States.
“The level of scrutiny that hospice transactions are undergoing now is high,” Kulik told Hospice News at the National Association for Home Care & Hospice’s...
Today's Sponsors
Today's Sponsor